Failure of AstraZeneca Trial Big Blow For Anti-Addiction Drugs: Report
NDTV
OUD is a chronic neurological disorder that causes compulsive, repeated use of opioid drugs, leading to prolonged self-administration.
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction and withdrawal, according to a report on Wednesday.
OUD is a chronic neurological disorder that causes compulsive, repeated use of opioid drugs, leading to prolonged self-administration.
The company recently terminated the development of AZD4041 during a Phase II trial, as the orexin 1 receptor antagonist demonstrated a drug-drug interaction with an antifungal.
Bihar Board 10th Result 2026: The board is expected to make an announcement soon.
The fire broke out early Wednesday at businessman Manoj Pugalia's house.
PM Modi strongly condemned the attacks on the region's energy infrastructure.
Chief Minister Himanta Biswa Sarma is contesting again from Jalukbari
During the raids, police said seven suspects were arrested.
The shootout is being linked to the rivalry between two gangs
IIT JAM 2026 Scorecards To Be Released On March 27
The accused has been identified as 30-year-old Merugu Sagar
The video, which was meant to highlight effective policing, instead triggered a wave of toxic comments.
GATE 2026 Result: GATE 2026 scorecards will be made available for download from March 27.
Tehran has targeted US assets while also striking energy facilities
